Mazyar Shadman, MD,MPH

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Stock Options
    Ineligible company:
    Koi Biotherapeutics
    Date added:
    11/03/2023
    Date updated:
    11/03/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Janssen
    Date added:
    11/03/2023
    Date updated:
    11/03/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Kite Pharma
    Date added:
    11/03/2023
    Date updated:
    11/03/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Eli Lily
    Date added:
    11/03/2023
    Date updated:
    11/03/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Fate therapeutics
    Date added:
    11/03/2023
    Date updated:
    11/03/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Merck
    Date added:
    11/03/2023
    Date updated:
    11/03/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Nurix
    Date added:
    11/03/2023
    Date updated:
    11/03/2023

Pages

Return to 2024 Seattle Cellular Therapy Summit: Updates and Focus on Accessibility